HOME >> BIOLOGY >> NEWS
Peramivir protects mice from lethal H5N1 infection

The antiviral drug peramivir might offer humans significant protection during a pandemic of the avian influenza virus H5N1, according to results of mouse studies conducted by investigators at St. Jude Children's Research Hospital.

Peramivir, an antiviral drug, blocks the ability of influenza viruses to use an enzyme called neuraminidase, thus preventing the release of new virus particles and their spread from one infected cell to another.

The St. Jude team studied different approaches to treating infected mice according to duration of administration (one day versus eight days); route of administration of peramivir (intramuscular injections alone versus intramuscular injections followed by oral administration) and frequency of administration on the first day of treatment (once versus twice). In all cases, the investigators administered peramivir to mice one hour after nasally administering a lethal Vietnam strain of H5N1 influenza virus.

The researchers reported 100 percent survival among 10 infected mice given intramuscular injections of peramivir daily for eight days. The drug also inhibited replication of the deadly strain of H5N1 virus in the lung, brain and spleen. The key to the high survival rate was treating the infected mice within 24 hours after infection with H5N1 and continuing the treatment for eight days. In contrast, a single intramuscular injection resulted in a 40 percent survival rate, while two intramuscular injections increased the rate to 60 percent. The single intramuscular injection did not completely inhibit H5N1 virus replication in the lungs and spleen, but did decrease the spread of virus to the brain.

"Peramivir should be given as soon as H5N1 infection is suspected, since onset of symptoms in infected humans can be delayed," said David A. Boltz, Ph.D., a postdoctoral fellow in the laboratory of Robert G. Webster in the Infectious Diseases department at St. Jude. "The drug could also be given
'"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-495-3061
St. Jude Children's Research Hospital
1-May-2007


Page: 1 2

Related biology news :

1. Reading ability protects brain from lead exposure
2. Research shows NPD1 protects a key component of vision
3. Drug protects brain cells in Huntingtons disease model, researchers find
4. A gene that protects from kidney disease
5. PINK1 protects from Parkinsons
6. Enzyme delivered in smaller package protects cells from radiation damage
7. Parkinsons protein protects neurons from stress induced cell death
8. Caspase-14 protects our skin against UVB and dehydration
9. Reproductive speed protects large animals from being hunted to extinction
10. Molecule that destroys bone also protects it, new research shows
11. Estrogen protects liver after traumatic injury

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2020)... ... 2020 , ... LabKey has released Sample Manager, sample ... processing within laboratories. , Built with input from a Product Advisory Council ... Sample Manager has been designed with an intuitive user interface providing a gateway ...
(Date:1/30/2020)... ... January 30, 2020 , ... Accelera Canada , a full-service firm ... market, is pleased to announce that the company has opened the doors of its ... in 2017. , “We are so thrilled to now have all our partners ...
(Date:1/29/2020)... ... January 29, 2020 , ... INDIGO Biosciences, ... testing solutions, has announced a record earnings year for 2019. With final numbers ... than a twenty percent increase in revenue and a thirty percent increase in ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... ... services in North America, today announced that the City of Fort Worth has ... biosolids management needs. Commencing in April of 2020, Synagro will assume operation of ...
(Date:2/3/2020)... (PRWEB) , ... February 03, 2020 , ... ... Travel, Financial Services Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare ... findings, listed quarterly. Each Index illustrates the following statistics:, ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... ... January 24, 2020 , ... The impact of new ... therapeutics, laboratory and clinical services during the first two decades of the 21st ... as Slone Partners celebrates its 20th anniversary this year, its evolution ...
Breaking Biology Technology:
Cached News: